Related Experiment Video
Updated: May 22, 2026
05:29
Behavioral Approaches to Studying Innate Stress in Zebrafish
Published on: May 1, 2019
Buspirone: what is it all about?
1Division of Experimental Medicine, Department of Medicine, Imperial College London, Du Cane Road, London, UK.
Brain Research
|May 22, 2012
Summary
Buspirone, an anxiolytic, acts as a partial agonist at serotonin 5-HT(1A) receptors. Research explores its potential beyond anxiety, including neurological and psychiatric conditions.
Area of Science:
- Pharmacology
- Neuroscience
- Psychiatry
Background:
- Buspirone is an anxiolytic drug.
- It acts as a partial agonist for serotonin 5-HT(1A) receptors and an antagonist for dopamine D(2) autoreceptors.
- Its precise mechanism of action is not fully understood but is thought to involve 5-HT(1A) receptor activity.
Purpose of the Study:
- To review the evidence for buspirone's underlying mechanisms of action.
- To explore its potential therapeutic uses in various neurological and psychiatric disorders.
- To highlight the need for further controlled studies to elucidate its exact mechanism and efficacy.
Main Methods:
- Literature review of existing studies on buspirone.
- Analysis of pharmacological data regarding receptor interactions.
- Synthesis of evidence for clinical applications.
Main Results:
- Buspirone's primary pharmacology is believed to be mediated via 5-HT(1A) receptors.
- Potential applications include managing side effects of Parkinson's disease therapy, ataxia, depression, social phobia, and behavioral disturbances associated with brain injury, Alzheimer's disease, dementia, and attention deficit disorder.
- Evidence suggests a role in various neurological and psychiatric conditions beyond generalized anxiety disorder.
Conclusions:
- Buspirone shows promise for treating a range of neurological and psychiatric conditions.
- Further rigorous research is essential to confirm its efficacy and clarify its mechanisms of action.
- Controlled studies are needed to establish buspirone's role in managing these diverse conditions.
Related Concept Videos
01:29Anxiolytic Drugs: Benzodiazepines and Buspirone
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
01:21Drugs for Treatment of Constipation-Predominant IBS
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
01:26Anxiolytic Drugs: Overview
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...